secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lineage Cell Therapeutics, Inc. (LCTX)
CIK:        0000876343
Form:       8-K
Filed at:   2024-05-14T23:59:59+00:00
Accession:  0000950170-24-059689
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lineage Cell Therapeutics files $40M ATM equity offering via B. Riley
---------------------------------------------------------------------

- Prospectus supplement filed May 14, 2024 to sell up to $39,966,424 of common shares at-the-market.
- Sales agent is B. Riley Securities, Inc. under agreement dated March 22, 2024.
- Shares offered pursuant to effective shelf registration statement (File No. 333-277758).
- Legal opinion from Sheppard Mullin on share legality included as exhibit.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/876343/000095017024059689/0000950170-24-059689-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/876343/000095017024059689/lctx-20240514.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-059689

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer